GPCR heteromers and their allosteric receptor-receptor interactions

Current Medicinal Chemistry

Volumn 19, Issue 3, 2012, Pages 356-363

  Fuxe, K ^a   Borroto Escuela, D O ^a   Marcellino, D ^a   Romero Fernandez W ^a   Frankowska, M ^b   Guidolin, D ^c   Filip, M ^b   Ferraro, L ^d   Woods, A S ^e   Tarakanov, A ^f   Ciruela, F ^g   Agnati, L F ^h   Tanganelli, S ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e NIDA IRP   (United States)

^f ST PETERSBURG INSTITUTE FOR INFORMATICS AND AUTOMATION   (Russian Federation)

^g UNIVERSITY OF BARCELONA   (Spain)

^h SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Adenosine receptor; Allosteric modulation; Dopamine receptors; GPCR; Moonlighting; Oligomers; Receptor G protein coupling; Receptor interface; Receptor mosaic; Receptor recognition; Receptor signaling; Receptor trafficking; Triplet homologies

Indexed keywords

ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ANTIPARKINSON AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; OLIGOMER;

ALLOSTERISM; ARTICLE; ATOMIC FORCE MICROSCOPY; BINDING SITE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CALCIUM BINDING; DIMERIZATION; DRUG DEPENDENCE; DRUG TARGETING; ENZYME ACTIVATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; OXIDATION; PARKINSON DISEASE; PREFRONTAL CORTEX; PROTEIN DOMAIN; PROTEIN FUNCTION; RECEPTOR BINDING; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; THERMODYNAMICS;

EID: 84857747091     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803414259     Document Type: Article

References (59)

1. Fuxe, K.; Dahlstrom, A.; Hoistad, M.; Marcellino, D.; Jansson, A.; Rivera, A.; Diaz-Cabiale, Z.; Jacobsen, K.; Tinner-Staines, B.; Hagman, B.; Leo, G.; Staines, W.; Guidolin, D.; Kehr, J.; Genedani, S.; Belluardo, N.; Agnati, L.F. From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: Wiring and volume transmission. Brain. Res. Rev., 2007, 55 (1), 17-54. (Pubitemid 47422227)
2. Fuxe, K.; Andersson, K.; Hokfelt, T.; Mutt, V.; Ferland, L.; Agnati, L.F.; Ganten, D.; Said, S.; Eneroth, P.; Gustafsson, J.A. Localization and possible function of peptidergic neurons and their interactions with central catecholamine neurons, and the central actions of gut hormones. Fed. Proc., 1979, 38 (9), 2333-2340. (Pubitemid 9252344)
3. Agnati, L.F.; Fuxe, K.; Zini, I.; Lenzi, P.; Hokfelt, T. Aspects on receptor regulation and isoreceptor identification. Med. Biol., 1980, 58 (4), 182-187. (Pubitemid 11164423)
4. Fuxe, K.; Agnati, L.F.; Benfenati, F.; Cimmino, M.; Algeri, S.; Hokfelt, T.; Mutt, V. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: Evidence for increased affinity and reduction in the number of binding sites. Acta. Physiol. Scand., 1981, 113 (4), 567-569. (Pubitemid 12183362)
5. Limbird, L.E.; Meyts, P.D.; Lefkowitz, R.J. Beta-adrenergic receptors: Evidence for negative cooperativity. Biochem. Biophys. Res. Commun., 1975, 64 (4), 1160-1168.
6. Zoli, M.; Agnati, L.F.; Hedlund, P.B.; Li, X.M.; Ferre, S.; Fuxe, K. Receptor-receptor interactions as an integrative mechanism in nerve cells. Mol. Neurobiol., 1993, 7 (3-4), 293-334.
7. Marshall, F.H.; White, J.; Main, M.; Green, A.; Wise, A. GABA(B) receptors function as heterodimers. Biochem. Soc. Trans., 1999, 27 (4), 530-535. (Pubitemid 29412482)
8. Cabello, N.; Gandia, J.; Bertarelli, D.C.; Watanabe, M.; Lluis, C.; Franco, R.; Ferre, S.; Lujan, R.; Ciruela, F. Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells. J. Neurochem., 2009, 109 (5), 1497-1507.
9. Carriba, P.; Navarro, G.; Ciruela, F.; Ferre, S.; Casado, V.; Agnati, L.; Cortes, A.; Mallol, J.; Fuxe, K.; Canela, E.I.; Lluis, C.; Franco, R. Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat. Methods., 2008, 5 (8), 727-733.
10. Borroto-Escuela, D.O.; Van Craenenbroeck, K.; Romero-Fernandez, W.; Guidolin, D.; Woods, A.S.; Rivera, A.; Haegeman, G.; Agnati, L.F.; Tarakanov, A.O.; Fuxe, K. Dopamine D2 and D4 receptor heteromerization and its allosteric receptor-receptor interactions. Biochem. Biophys. Res. Commun., 2011, 404 (4), 928-934.
11. Fuxe, K.; Marcellino, D.; Leo, G.; Agnati, L.F. Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis. Curr. Opin. Pharmacol., 2010, 10 (1), 14-22.
12. Monod, J.; Wyman, J.; Changeux, J.P. On the Nature of Allosteric Transitions: A Plausible Model. J. Mol. Biol., 1965, 12 88-118.
13. Koshland, D.E., Jr.; Nemethy, G.; Filmer, D. Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochemistry, 1966, 5 (1), 365-385.
14. Tsai, C.J.; Del Sol, A.; Nussinov, R. Protein allostery, signal transmission and dynamics: A classification scheme of allosteric mechanisms. Mol. Biosyst., 2009, 5 (3), 207-216.
15. Gouldson, P.R.; Higgs, C.; Smith, R.E.; Dean, M.K.; Gkoutos, G.V.; Reynolds, C.A. Dimerization and domain swapping in G-protein-coupled receptors: A computational study. Neuropsychopharmacology, 2000, 23 (4 Suppl), S60-77.
16. Guo, W.; Urizar, E.; Kralikova, M.; Mobarec, J.C.; Shi, L.; Filizola, M.; Javitch, J.A. Dopamine D2 receptors form higher order oligomers at physiological expression levels. EMBO. J., 2008, 27 (17), 2293-2304.
17. Guidolin, D.; Ciruela, F.; Genedani, S.; Guescini, M.; Tortorella, C.; Albertin, G.; Fuxe, K.; Agnati, L.F. Bioinformatics and mathematical modelling in the study of receptor-receptor interactions and receptor oligomerization: Focus on adenosine receptors. Biochim. Biophys. Acta., 2011, 1808 (5), 1267-1283.
18. Ciruela, F.; Burgueno, J.; Casado, V.; Canals, M.; Marcellino, D.; Goldberg, S.R.; Bader, M.; Fuxe, K.; Agnati, L.F.; Lluis, C.; Franco, R.; Ferre, S.; Woods, A.S. Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Anal. Chem., 2004, 76 (18), 5354-5363. (Pubitemid 39249416)
19. Woods, A.S.; Ciruela, F.; Fuxe, K.; Agnati, L.F.; Lluis, C.; Franco, R.; Ferre, S. Role of electrostatic interaction in receptor-receptor heteromerization. J. Mol. Neurosci., 2005, 26 (2-3), 125-132. (Pubitemid 41389405)
20. Tarakanov, A.O.; Fuxe, K.G. Triplet puzzle: Homologies of receptor heteromers. J. Mol. Neurosci., 2010, 41 (2), 294-303.
21. Tarakanov, A.O.; Fuxe, K.G. The triplet puzzle of homologies in receptor heteromers exists also in other types of protein-protein interactions. J. Mol. Neurosci., 2011, 44 (3), 173-177.
22. Woods, A.S.; Ferre, S. Amazing stability of the arginine-phosphate electrostatic interaction. J. Proteome. Res., 2005, 4 (4), 1397-1402. (Pubitemid 41208697)
23. Fuxe, K.; Ferre, S.; Canals, M.; Torvinen, M.; Terasmaa, A.; Marcellino, D.; Goldberg, S.R.; Staines, W.; Jacobsen, K.X.; Lluis, C.; Woods, A.S.; Agnati, L.F.; Franco, R. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J. Mol. Neurosci., 2005, 26 (2-3), 209-220.
24. Torvinen, M.; Marcellino, D.; Canals, M.; Agnati, L.F.; Lluis, C.; Franco, R.; Fuxe, K. Adenosine A2A receptor and dopamine D3 receptor interactions: Evidence of functional A2A/D3 heteromeric complexes. Mol. Pharmacol., 2005, 67 (2), 400-407. (Pubitemid 40216732)
25. Borroto-Escuela, D.O.; Marcellino, D.; Narvaez, M.; Flajolet, M.; Heintz, N.; Agnati, L.; Ciruela, F.; Fuxe, K. A serine point mutation in the adenosine A2AR C-terminal tail reduces receptor heteromerization and allosteric modulation of the dopamine D2R. Biochem. Biophys. Res. Commun., 2010, 394 (1), 222-227.
26. Borroto-Escuela, D.O.; Romero-Fernandez, W.; Tarakanov, A.O.; Gomez-Soler, M.; Corrales, F.; Marcellino, D.; Narvaez, M.; Frankowska, M.; Flajolet, M.; Heintz, N.; Agnati, L.F.; Ciruela, F.; Fuxe, K. Characterization of the A2AR-D2R interface: Focus on the role of the C-terminal tail and the transmembrane helices. Biochem. Biophys. Res. Commun., 2010, 402 (4), 801-807.
27. Borroto-Escuela, D.O.; Correia, P.A.; Romero-Fernandez, W.; Narvaez, M.; Fuxe, K.; Ciruela, F.; Garriga, P. Muscarinic receptor family interacting proteins: Role in receptor function. J. Neurosci. Methods., 2011, 195 (2), 161-169.
28. Kenakin, T.; Agnati, L.F.; Caron, M.; Fredholm, B.; Guidoli, D.; Kobilka, B.; Lefkowitz, R.W.; Lohse, M.; Woods, A.; Fuxe, K. International Workshop at the Nobel Forum, Karolinska Institutet on G protein-coupled receptors: Finding the words to describe monomers, oligomers, and their molecular mechanisms and defining their meaning. Can a consensus be reached? J. Recept. Signal. Transduct. Res., 2011, 30 (5), 284-286.
29. Jeffery, C.J. Moonlighting proteins-an update. Mol. Biosyst., 2009, 5 (4), 345-350.
30. Borroto-Escuela, D.O.; Tarakanov, A.O.; Guidolin, D.; Ciruela, F.; Agnati, L.F.; Fuxe, K. Moonlighting characteristics of G protein-coupled receptors: Focus on receptor heteromers and relevance for neurodegeneration. IUBMB. Life., 2011, 63 (7), 463-472.
31. Rashid, A.J.; So, C.H.; Kong, M.M.; Furtak, T.; El-Ghundi, M.; Cheng, R.; O'Dowd, B.F.; George, S.R. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc. Natl. Acad. Sci. U S A., 2007, 104 (2), 654-659. (Pubitemid 46123080)
32. Borroto-Escuela, D.O.; Romero-Fernandez, W.; Tarakanov, A.O.; Ciruela, F.; Agnati, L.F.; Fuxe, K. On the existence of a possible A2A-D2-beta-Arrestin2 complex: A2A agonist modulation of D2 agonist-induced betaarrestin2 recruitment. J. Mol. Biol., 2011, 406 (5), 687-699.
33. Borroto-Escuela, D.O.; Romero-Fernandez, W.; Tarakanov, A.O.; Marcellino, D.; Ciruela, F.; Agnati, L.F.; Fuxe, K. Dopamine D2 and 5-hydroxytryptamine 5-HT(A) receptors assemble into functionally interacting heteromers. Biochem. Biophys. Res. Commun., 2010, 401 (4), 605-610.
34. Woods, A.S.; Marcellino, D.; Jackson, S.N.; Franco, R.; Ferre, S.; Agnati, L.F.; Fuxe, K. How calmodulin interacts with the adenosine A(2A) and the dopamine D(2) receptors. J. Proteome. Res., 2008, 7 (8), 3428-3434.
35. Vilardaga, J.P.; Nikolaev, V.O.; Lorenz, K.; Ferrandon, S.; Zhuang, Z.; Lohse, M.J. Conformational cross-talk between alpha2A-adrenergic and muopioid receptors controls cell signaling. Nat. Chem. Biol., 2008, 4 (2), 126-131.
36. Vilardaga, J.P.; Bunemann, M.; Krasel, C.; Castro, M.; Lohse, M.J. Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nat. Biotechnol., 2003, 21 (7), 807-812. (Pubitemid 36791401)
37. Harfstrand, A.; Fuxe, K.; Melander, T.; Hokfelt, T.; Agnati, L.F. Evidence for a cardiovascular role of central galanin neurons: Focus on interactions with alpha 2-adrenergic and neuropeptide Y mechanisms. J. Cardiovasc. Pharmacol., 1987, 10 Suppl 12 S199-204.
38. Harfstrand, A.; Fuxe, K.; Agnati, L.; Fredholm, B. Reciprocal interactions between alpha 2-adrenoceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat. A biochemic and autoradiographic analysis. J. Neural. Transm., 1989, 75 (2), 83-99. (Pubitemid 19033927)
39. Yang, S.N.; Fior, D.R.; Hedlund, P.B.; Narvaez, J.A.; Agnati, L.F.; Fuxe, K. Coinjections of NPY(1-36) or [Leu31,Pro34]NPY with adrenaline in the nucleus tractus solitarius of the rat counteract the vasodepressor responses to adrenaline. Neurosci. Lett., 1994, 171 (1-2), 27-31.
40. Liu, F.; Wan, Q.; Pristupa, Z.B.; Yu, X.M.; Wang, Y.T.; Niznik, H.B. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Nature, 2000, 403 (6767), 274-280. (Pubitemid 30062376)
41. Salter, M.W. D1 and NMDA receptors hook up: Expanding on an emerging theme. Trends. Neurosci., 2003, 26 (5), 235-237. (Pubitemid 36556151)
42. Lee, F.J.; Xue, S.; Pei, L.; Vukusic, B.; Chery, N.; Wang, Y.; Wang, Y.T.; Niznik, H.B.; Yu, X.M.; Liu, F. Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell, 2002, 111 (2), 219-230. (Pubitemid 35292442)
43. Li, Y.C.; Liu, G.; Hu, J.L.; Gao, W.J.; Huang, Y.Q. Dopamine D(1) receptormediated enhancement of NMDA receptor trafficking requires rapid PKCdependent synaptic insertion in the prefrontal neurons. J. Neurochem., 2010, 114 (1), 62-73.
44. Nai, Q.; Li, S.; Wang, S.H.; Liu, J.; Lee, F.J.; Frankland, P.W.; Liu, F. Uncoupling the D1-N-methyl-D-aspartate (NMDA) receptor complex promotes NMDA-dependent long-term potentiation and working memory. Biol. Psychiatry., 2010, 67 (3), 246-254.
45. Gurevich, V.V.; Gurevich, E.V. GPCR monomers and oligomers: It takes all kinds. Trends. Neurosci., 2008, 31 (2), 74-81.
46. Gurevich, V.V.; Gurevich, E.V. How and why do GPCRs dimerize? Trends Pharmacol. Sci., 2008, 29 (5), 234-240.
47. Fuxe, K.; Marcellino, D.; Borroto-Escuela, D.O.; Guescini, M.; Fernandez-Duenas, V.; Tanganelli, S.; Rivera, A.; Ciruela, F.; Agnati, L.F. Adenosinedopamine interactions in the pathophysiology and treatment of CNS disorders. CNS. Neurosci. Ther., 2010, 16 (3), e18-42.
48. Agnati, L.F.; Guidolin, D.; Vilardaga, J.P.; Ciruela, F.; Fuxe, K. On the expanding terminology in the GPCR field: The meaning of receptor mosaics and receptor heteromers. J. Recept. Signal. Transduct. Res., 2010, 30 (5), 287-303.
49. Fuxe, K.; Marcellino, D.; Borroto-Escuela, D.O.; Frankowska, M.; Ferraro, L.; Guidolin, D.; Ciruela, F.; Agnati, L.F. The changing world of G proteincoupled receptors: From monomers to dimers and receptor mosaics with allosteric receptor-receptor interactions. J. Recept. Signal. Transduct. Res., 2010, 30 (5), 272-283.
50. Fuxe, K.; Marcellino, D.; Rivera, A.; Diaz-Cabiale, Z.; Filip, M.; Gago, B.; Roberts, D.C.; Langel, U.; Genedani, S.; Ferraro, L.; de la Calle, A.; Narvaez, J.; Tanganelli, S.; Woods, A.; Agnati, L.F. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain. Res. Rev., 2008, 58 (2), 415-452.
51. Fuxe, K.; Marcellino, D.; Genedani, S.; Agnati, L. Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease. Mov. Disord., 2007, 22 (14), 1990-2017.
52. Antonelli, T.; Fuxe, K.; Agnati, L.; Mazzoni, E.; Tanganelli, S.; Tomasini, M.C.; Ferraro, L. Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias. J. Neurol. Sci., 2006, 248 (1-2), 16-22. (Pubitemid 44647295)
53. Schwarzschild, M.A.; Agnati, L.; Fuxe, K.; Chen, J.F.; Morelli, M. Targeting adenosine A2A receptors in Parkinson's disease. Trends. Neurosci., 2006, 29 (11), 647-654. (Pubitemid 44602262)
54. Fuxe, K.; Marcellino, D.; Woods, A.S.; Giuseppina, L.; Antonelli, T.; Ferraro, L.; Tanganelli, S.; Agnati, L.F. Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: Relevance for schizophrenia. J. Neural. Transm., 2009, 116 (8), 923-939.
55. Ciruela, F.; Gomez-Soler, M.; Guidolin, D.; Borroto-Escuela, D.O.; Agnati, L.F.; Fuxe, K.; Fernandez-Duenas, V. Adenosine receptor containing oligomers: Their role in the control of dopamine and glutamate neurotransmission in the brain. Biochim. Biophys. Acta., 2011, 1808 (5), 1245-1255.
56. Hoare, S.R.; Strange, P.G. Regulation of D2 dopamine receptors by amiloride and amiloride analogs. Mol. Pharmacol., 1996, 50 (5), 1295-1308. (Pubitemid 26384868)
57. Soriano, A.; Ventura, R.; Molero. A.; Hoen, R.; Casadó, V.; Cortés, A.; Fanelli, F.; Albericio, F.; Lluís, C.; Franco, R.; Royo, M. Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers. J.Med.Chem., 2009, 52(18), 5590-602.
58. Jaakola, V.P.; Griffith, M.T.; Hanson, M.A.; Cherezov, V.; Chien, E.Y.; Lane, J.R.; Ijzerman, A.P.; Stevens, R.C. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science, 2008, 322 (5905), 1211-1217.
59. Li, J.; Edwards, P.C.; Burghammer, M.; Villa, C.; Schertler, G.F. Structure of bovine rhodopsin in a trigonal crystal form. J. Mol. Biol., 2004, 343 (5), 1409-1438. (Pubitemid 39387834)